Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Price Hikes Protect Cephalon, Lining Up Nuvigil Ducks

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm to add sales reps after ending Takeda co-promotion deal.
Advertisement

Related Content

Panel COVERS Problems With Cephalon’s Fentora
Amrix And Treanda Take-up Bodes Well For Cephalon
FDA Approves Cephalon’s Nuvigil With Bolded Warning For Rash
Cephalon To More Than Double Provigil Sales Team Through Takeda Co-Promotion Deal
Cephalon To More Than Double Provigil Sales Team Through Takeda Co-Promotion Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS068326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel